Intervention

DMARD

ClinicalTrials.gov intervention label

Clinical trials4
Recruiting0
Common conditions3
Lead sponsors shown3

Clinical trials

4 shown
A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid ArthritisNCT01995201 · 2013-09-01
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid ArthritisNCT01251120 · 2011-11-01
TERMINATED
Ultrasound Utility in Routine Clinical PractiseNCT03124225 · 2011-06-01
COMPLETED
Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudyNCT00116714 · 2001-10-01
COMPLETED

Trial status mix

COMPLETED3
TERMINATED1

Phase mix

PHASE31
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.